Youmiao Zeng

Wuhan, 430071, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

PDK4-dependent lactate production and lactylation promote renal calcium oxalate crystal-induced EMT and mitochondrial dysfunction via the TGF-β/SMAD3/GPX4 axis.

PDK4-dependent lactate production and lactylation promote renal calcium oxalate crystal-induced EMT and mitochondrial dysfunction via the TGF-β/SMAD3/GPX4 axis.

Journal: Cellular signalling
Published: May 17, 2026

G6PC Downregulation Promotes Renal Calcium Oxalate Stone Formation via Lactate-Induced SNAIL1 K206 Lactylation and Epithelial-Mesenchymal Transition.

G6PC Downregulation Promotes Renal Calcium Oxalate Stone Formation via Lactate-Induced SNAIL1 K206 Lactylation and Epithelial-Mesenchymal Transition.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 16, 2026

ACSL5 regulated acetyl-CoA to promote bladder cancer cellular senescence via 53BP1 acetylation.

ACSL5 regulated acetyl-CoA to promote bladder cancer cellular senescence via 53BP1 acetylation.

Journal: Oncogene
Published: January 10, 2025

Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation.

Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation.

Journal: Cancer research
Published: November 08, 2024

Genotype-phenotype relationship and genetics study of 115 cases with Wilson's disease

Genotype-phenotype relationship and genetics study of 115 cases with Wilson's disease

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: July 04, 2024

m6A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis.

m6A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis.

Journal: Oncogene
Published: April 09, 2024

Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC.

Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC.

Journal: BMC cancer
Published: February 16, 2024

m6A-Mediated Induction of 7-Dehydrocholesterol Reductase Stimulates Cholesterol Synthesis and cAMP Signaling to Promote Bladder Cancer Metastasis.

m6A-Mediated Induction of 7-Dehydrocholesterol Reductase Stimulates Cholesterol Synthesis and cAMP Signaling to Promote Bladder Cancer Metastasis.

Journal: Cancer research
Published: November 22, 2023

Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer.

Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer.

Journal: Journal of translational medicine
Published: November 20, 2023

Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression.

Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression.

Journal: Cancer research
Published: March 29, 2023

A Metabolism-Related Gene Landscape Predicts Prostate Cancer Recurrence and Treatment Response.

A Metabolism-Related Gene Landscape Predicts Prostate Cancer Recurrence and Treatment Response.

Journal: Frontiers in immunology
Published: December 17, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026